329 related articles for article (PubMed ID: 12574337)
1. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
Gunturi A; Berg RE; Forman J
J Immunol; 2003 Feb; 170(4):1737-45. PubMed ID: 12574337
[TBL] [Abstract][Full Text] [Related]
2. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
[TBL] [Abstract][Full Text] [Related]
3. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
[TBL] [Abstract][Full Text] [Related]
5. The role of CD94/NKG2 in innate and adaptive immunity.
Gunturi A; Berg RE; Forman J
Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
[TBL] [Abstract][Full Text] [Related]
6. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.
McMahon CW; Zajac AJ; Jamieson AM; Corral L; Hammer GE; Ahmed R; Raulet DH
J Immunol; 2002 Aug; 169(3):1444-52. PubMed ID: 12133970
[TBL] [Abstract][Full Text] [Related]
7. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
[TBL] [Abstract][Full Text] [Related]
8. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
9. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
11. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
Gunturi A; Berg RE; Crossley E; Murray S; Forman J
Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
[TBL] [Abstract][Full Text] [Related]
12. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
Wojtasiak M; Jones CM; Sullivan LC; Winterhalter AC; Carbone FR; Brooks AG
Int Immunol; 2004 Sep; 16(9):1333-41. PubMed ID: 15302848
[TBL] [Abstract][Full Text] [Related]
13. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
[TBL] [Abstract][Full Text] [Related]
14. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
Williams NS; Kubota A; Bennett M; Kumar V; Takei F
Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
[TBL] [Abstract][Full Text] [Related]
17. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
20. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses.
Ortega C; Romero P; Palma A; Orta T; Peña J; García-Vinuesa A; Molina IJ; Santamaría M
Immunol Cell Biol; 2004 Dec; 82(6):587-95. PubMed ID: 15550116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
